Chronic Obstructive Pulmonary Disease
Conditions
Keywords
COPD, health promotion, musical instrument, singing
Brief summary
This study was conducted as a randomized controlled experimental study to determine the effect of singing or playing melodica activity applied to chronic obstructive pulmonary patients on symptoms, self-efficacy level, and exercise capacity of patients.
Detailed description
The research was carried out in the chest diseases polyclinics of a hospital in Trabzon city center between September 2020 and August 2021 with 30 patients: 15 in the control group and 15 in the song/melodica group. Based on Pender's health promotion model, the control group received training and counseling for ten weeks, including face-toface training and telephone follow-up. According to Pender's health promotion model, patients in the song/melodica group were given face-to-face training once, singing/playing the melodica training twice, and counseling and follow-up over the phone twice, with 15- day intervals. The data were collected with a patient information form and scales examining disease symptoms, self-efficacy, and exercise capacity. To evaluate the data, ttest, Mann-Whitney U, ANOVA, Kruskal Wallis test were used for independent groups to evaluate changes over time, and paired two-sample t-test, Wilcoxon test, and ANOVA test were used in repetitive measurements for dependent groups. .
Interventions
The patients who were divided into groups according to their wishes to sing or play the melodica were given warm-up training before the song group (20 min. warm-up training including breathing exercises, 20 min. singing) and melodica group (20 min. breathing). warm-up training including exercises, playing melodica for 20 minutes) was given with the researcher under the leadership of an experienced music teacher. For two weeks, a total of 40 minutes of song/melodica training was given per week. The singing group was given an assignment to sing for at least 20 minutes a day and the melodica playing group to play the melodica for at least 20 minutes a day. The patients were asked to do their song/melodica homework for at least 20-30 minutes a day, and then they were told about the follow-up papers. Patients in the song/melody group were followed up by telephone twice a total of 15 days at the 5th and 7th weeks.
In the first interview, the pre-tests were applied by the researcher with the face-to-face interview technique. Afterwards, nursing education was given through the training guide prepared according to Pender's health promotion model. The control group was followed up and counseled by phone, twice a day, twice a day, in the 5th and 7th weeks. Post-tests were applied at week 10 to evaluate the effectiveness of the interventions.
Sponsors
Study design
Masking description
While taking informed consent, the purpose and content of the study were explained to the participants.
Intervention model description
Power analysis was used to calculate the sample size of the study. The power of the test was calculated with the G\*Power 3.1 program. The effect size was calculated as 1.24 according to the study of Canga et al., which was a similar study that was taken as a reference during the calculation process (28). The sample consisted of a total of 30 patients, 15 of whom were control and 15 were song/melodica, determined by power analysis at 95% confidence interval, 5% significance level and 1.24 effect size (df=28; t=1.701).
Eligibility
Inclusion criteria
* 18 years and older, * Having been diagnosed with COPD by the physician based on the results of the pulmonary function test taken with spirometry according to the GOLD criteria, who are in the stable period of COPD, * Applying to thoracic polyclinics, * not bedridden, * Does not have vision and hearing problems that do not interfere with communication, * Patients who can complete the six-minute walk test, * Willing to sing and/or play melodica * Patients who agreed to participate in the study and who read and signed the informed consent form were included in the sample.
Exclusion criteria
- * Those who do not agree to participate in the research, * with asthma, * with a diagnosis of cancer, * with a diagnosis of Covid-19, * Having unstable angina or myocardial infarction in the last 1 month, * Having a resting heart rate \>120/min, * Patients with a resting systolic blood pressure of \>180 mmHg and a diastolic blood pressure of \>100 mmHg (183) were excluded from the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Modifiye Medical Research Council (mMMC) Dyspnea scale | 10 weeks | Dyspnea scores of the patients were recorded in the pre-test and post-test.The Medical Research Council Scale (mMRC) consists of five items based on various physical activities that cause dyspnea. On this scale, patients are asked to simply select the activity that produces the feeling of dyspnea. Scoring is between 0-4. Minimum, maximum, median and mean values were evaluated for each group and compared between groups. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| COPD Assessment Test (CAT) | 10 weeks | The CAT scale, which rates the effects of chronic obstructive pulmonary disease on the patient and deterioration in health, consists of eight parameters that question cough, sputum, chest symptoms, fatigue, and confidence in leaving home. The score that can be obtained from the scale is a minimum of 0 and a maximum of 40 points. CAT scores of the patients were recorded in the pre-test and post-test. Minimum, maximum, median and mean values were evaluated for each group and compared between groups. |
Other
| Measure | Time frame | Description |
|---|---|---|
| six minutes walking tests | 10 weeks | The 6-minute walking distances of the patients were recorded in the pre-test and post-test. Minimum, maximum, median and mean values were evaluated for each group and compared between groups. |
| COPD Self-Efficacy Scale | 10 weeks | COPD Self-Efficacy Scale scores were recorded in the pre-test and post-test. A minimum of 34 points and a maximum of 170 points can be obtained from the scale as a total score. Minimum, maximum, median and mean values were evaluated for each group and compared between groups. |
| Hospital Anxiety Depression (HAD) Scale | 10 weeks | Hospital Anxiety Depression (HAD) Scale scores were recorded in the pre-test and post-test.The answers are evaluated in a four-point Likert format and are scored between zero and three. The lowest score that can be obtained from both subscales is 0, and the highest score is 21. Minimum, maximum, median and mean values were evaluated for each group and compared between groups. |
Countries
Turkey (Türkiye)